Skip to main content
Premium Trial:

Request an Annual Quote

LSBC s Revenues Take Dive, Losses Narrow in Q1

NEWS YORK, April 30 (GenomeWeb News) - Large Scale Biology reported a sharp decline in revenues as well as narrowed losses for the first quarter of 2004 on Wednesday.

 

The company's revenues totaled $320,000, down from $850,000 during the same quarter last year.

 

Research and development costs were $2.2 million, down from $3.2 million during the same period a year ago.

 

LSBC's net loss amounted to $4.3 million, or $.16 per share, down from $7.6 million, or $.3 per share, during the year-ago period.

 

As of March 31, LSBC had $11.2 million in cash and marketable securities.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.